Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy

Journal of Clinical Oncology

Volumn 29, Issue 29, 2011, Pages 3885-3891

  Arvold, Nils D ^a   Taghian, Alphonse G ^b   Niemierko, Andrzej ^b   Abi Raad, Rita F ^b   Sreedhara, Meera ^c   Nguyen, Paul L ^c   Bellon, Jennifer R ^c   Wong, Julia S ^c   Smith, Barbara L ^b   Harris, Jay R ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER STAGING; CONSERVATIVE TREATMENT; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGE FACTORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 80054005684     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.1105     Document Type: Article

References (63)

1. Kroman N, Jensen MB, Wohlfahrt J, et al: Factors influencing the effect of age on prognosis in breast cancer: Population based study. BMJ 320:474-478, 2000 (Pubitemid 30173116)
2. Albain KS, Allred DC, Clark GM: Breast cancer outcome and predictors of outcome: Are there age differentials? J Natl Cancer Inst Monogr 16:35-42, 1994
3. Swanson GM, Lin CS: Survival patterns among younger women with breast cancer: The effects of age, race, stage, and treatment. J Natl Cancer Inst Monogr 16:69-77, 1994
4. Han W, Kim SW, Park IA, et al: Young age: An independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82, 2004
5. Fisher ER, Anderson S, Redmond C, et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 8:161-166, 1992
6. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002 (Pubitemid 35176241)
7. Voogd AC, Nielsen M, Peterse JL, et al: Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 19:1688-1697, 2001 (Pubitemid 32230869)
8. Nixon AJ, Neuberg D, Hayes DF, et al: Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888-894, 1994 (Pubitemid 24145313)
9. Elkhuizen PH, van de Vijver MJ, Hermans J, et al: Local recurrence after breast-conserving treatment for invasive breast cancer: High incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40:859-867, 1998 (Pubitemid 28150804)
10. Kroman N, Holtveg H, Wohlfahrt J, et al: Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 100:688-693, 2004 (Pubitemid 38176844)
11. Kurtz JM, Jacquemier J, Amalric R, et al: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8:591-598, 1990
12. Anderson SJ, Wapnir I, Dignam JJ, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27:2466-2473, 2009
13. Stotter AT, McNeese MD, Ames FC, et al: Predicting the rate and the extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64:2217-2225, 1989 (Pubitemid 19282834)
14. Mate TP, Carter D, Fischer DB, et al: A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer 58:1995-2002, 1986
15. Ries LAG, Melbert D, Krapcho M, et al (eds): Surveillance, Epidemiology, and End Results Cancer Statistics Review, 1975-2005. Bethesda, MD, National Cancer Institute, 2008
16. American Cancer Society: Cancer Facts and Figures 2010. Atlanta, GA, American Cancer Society, 2010
17. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002 (Pubitemid 35176242)
18. Jacobson JA, Danforth DN, Cowan KH, et al: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907-911, 1995
19. Blichert-Toft M, Rose C, Andersen JA, et al: Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis - Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 11:19-25, 1992
20. van Dongen JA, Voogd AC, Fentiman IS, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000
21. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials. Lancet 366:2087-2106, 2005
22. Boyages J, Recht A, Connolly JL, et al: Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 19:29-41, 1990 (Pubitemid 20264687)
23. Bollet MA, Sigal-Zafrani B, Mazeau V, et al: Age remains the first prognostic factor for locoregional breast cancer recurrence in young (< 40 years) women treated with breast conserving surgery first. Radiother Oncol 82:272-280, 2007 (Pubitemid 46350796)
24. Vrieling C, Collette L, Fourquet A, et al: Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39:932-944, 2003
25. Coulombe G, Tyldesley S, Speers C, et al: Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 67:1282-1290, 2007
26. McCormick B: Selection criteria for breast conservation: The impact of young and old age and collagen vascular disease. Cancer 74:430-435, 1994
27. White JR, Halberg FE, Rabinovitch R, et al: American College of Radiology appropriateness criteria on conservative surgery and radiation: Stages I and II breast carcinoma. J Am Coll Radiol 5:701-713, 2008 (Pubitemid 351749595)
28. Jobsen JJ, van der Palen J, Ong F, et al: The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 57:724-731, 2003 (Pubitemid 37194298)
29. Perou CM, Sørlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
30. Sørlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874, 2001 (Pubitemid 32878711)
31. Oh DS, Troester MA, Usary J, et al: Estrogen-regulated genes predict survival in hormone receptorpositive breast cancers. J Clin Oncol 24:1656-1664, 2006 (Pubitemid 46622136)
32. Rouzier R, Perou CM, Symmans WF, et al: Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678-5685, 2005 (Pubitemid 41170290)
33. Tang P, Skinner KA, Hicks DG: Molecular classification of breast carcinomas by immunohistochemical analysis: Are we ready? Diagn Mol Pathol 18:125-132, 2009
34. Nguyen PL, Taghian AG, Katz MS, et al: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast conserving therapy. J Clin Oncol 26:2373-2378, 2008
35. Anders CK, Hsu DS, Broadwater G, et al: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324-3330, 2008
36. Cheang MC, Chia SK, Voduc D, et al: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736-750, 2009
37. Trihia H, Murray S, Price K, et al: Ki-67 expression in breast carcinoma: Its association with grading systems, clinical parameters, and other prognostic factors - A surrogate marker? Cancer 97:1321-1331, 2003
38. Spyratos F, Ferrero-Poüs M, Trassard M, et al: Correlation between MIB-1 and other proliferation markers: Clinical implications of the MIB-1 cutoff value. Cancer 94:2151-2159, 2002 (Pubitemid 34411971)
39. Goldhirsch A, Wood WC, Coates AS, et al: Strategies for subtypes: Dealing with the diversity of breast cancer - Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736-1747, 2011
40. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al: Trastuzumab after adjuvant chemotherapy in HER-2-positive breast cancer. N Engl J Med 353:1659-1672, 2005 (Pubitemid 41464705)
41. Romond EH, Perez EA, Bryant J, et al: Trastuzumab plus adjuvant chemotherapy for operable HER-2-positive breast cancer. N Engl J Med 353:1673-1684, 2005 (Pubitemid 41464706)
42. Gray RJ: A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
43. Cabioglu N, Hunt KK, Buchholz TA, et al: Improving local control with breast-conserving therapy: A 27-year single-institution experience. Cancer 104:20-29, 2005 (Pubitemid 40847748)
44. Pass H, Vicini FA, Kestin LL, et al: Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 101:713-720, 2004 (Pubitemid 39030925)
45. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989 (Pubitemid 19094701)
46. Fisher B, Redmond C, Dimitrov NV, et al: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:473-478, 1989 (Pubitemid 19062521)
47. Buchholz TA, Tucker SL, Erwin J, et al: Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19:2240-2246, 2001 (Pubitemid 32372325)
48. Fisher B, Dignam J, Bryant J, et al: Five versus more than five years of tamoxifen for lymph nodenegative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl Cancer Inst 93:684-690, 2001 (Pubitemid 32492809)
49. Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002 (Pubitemid 35191016)
50. Cancello G, Maisonneuve P, Rotmensz N, et al: Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (< 35 years) with operable breast cancer. Ann Oncol 21:1974-1981, 2010
51. Voduc KD, Cheang MC, Tyldesley S, et al: Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684-1691, 2010
52. Leong C, Boyages J, Jayasinghe UW, et al: Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 100:1823-1832, 2004
53. Recht A, Connolly JL, Schnitt SJ, et al: The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 14:3-10, 1988 (Pubitemid 18059122)
54. Solin LJ, Fowble B, Schultz DJ, et al: Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 16:373-381, 1989 (Pubitemid 19077202)
55. van Dongen JA, Bartelink H, Fentiman IS, et al: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conversation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A:801-805, 1992
56. Clarke DH, Lê MG, Sarrazin D, et al: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11:137-145, 1985 (Pubitemid 15169362)
57. Fowble BL, Schultz DJ, Overmoyer B, et al: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30:23-33, 1994 (Pubitemid 24291110)
58. Klauber-DeMore N: Tumor biology of breast cancer in young women. Breast Dis 23:9-15, 2005-2006
59. Lehmann BD, Bauer JA, Chen X, et al: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121:2750-2767, 2011
60. Anders CK, Fan C, Parker JS, et al: Breast carcinomas arising at a young age: Unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29:e18-e20, 2011
61. Carey LA, Perou CM, Livasy CA, et al: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502, 2006 (Pubitemid 43854964)
62. Cheng CW, Das IJ, Tang W, et al: Dosimetric comparison of treatment planning systems in irradiation of breast with tangential fields. Int J Radiat Oncol Biol Phys 38:835-842, 1997 (Pubitemid 27310555)
63. Delaney G, Beckham W, Veness M, et al: Three-dimensional dose distribution of tangential breast irradiation: Results of a multicentre phantom dosimetry study. Radiother Oncol 57:61-68, 2000